In a nutshell This study investigated the effectiveness and safety of rupatadine (RUP; Rupafin) and montelukast (MON; Singulair) as additive therapies for patients with rheumatoid arthritis (RA). The authors concluded that RUP and MON provided clinical and functional improvements in these patients. Some background RA is a chronic autoimmune,...
Read More
In a nutshell This phase 2 trial will investigate the safety and effectiveness of ATI-450 in patients with rheumatoid arthritis (RA). The main outcomes will be the number of side effects and the change in disease activity (DA). This trial is recruiting at several locations in the United States. The details Rheumatoid...
Read More
In a nutshell This study investigated the effectiveness of combined ultrasound for assessing synovitis in rheumatoid arthritis (RA) patients starting abatacept (Orencia) with methotrexate (Trexall). The study concluded that the ultrasound technique and the drug combination were effective. Some background RA is a chronic autoimmune disease...
Read More
In a nutshell The authors analyzed the safety and effectiveness of certolizumab pegol (Cimzia) in combination with methotrexate (Trexall) in the treatment of rheumatoid arthritis (RA). Some background In RA, high levels of immune system proteins are generated. This causes inflammation, leading to chronic...
Read More
In a nutshell This study examined the short term benefits and harms of using methotrexate (Rheumatrex, Trexall) for treating rheumatoid arthritis. Some background Rheumatoid arthritis is a chronic (long-term) disease that leads to inflammation of the joints. The severity of patients’ symptoms can be graded using the ACR 50 (the American...
Read More
